| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $149.2M | +99.2% |
| Cost of Revenue | $76.8M | +270.7% |
| Gross Profit | $72.3M | +33.5% |
| R&D Expense | $6.6M | -48.4% |
| SG&A Expense | $49.7M | +63.9% |
| Operating Income | -$31.4M | +9.0% |
| Interest Expense | $7.6M | +4.3% |
| Net Income | -$39.0M | +10.8% |
| EPS (Basic) | -$0.59 | +57.2% |
| EPS (Diluted) | -$0.59 | +57.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $28.1M | +52.4% |
| Accounts Receivable | $16.5M | -29.5% |
| Inventory | $4.3M | +1.9% |
| Current Assets | $61.6M | +5.9% |
| Total Assets | $141.6M | +0.5% |
| Current Liabilities | $30.5M | -2.4% |
| Long-term Debt | $65.8M | +19.3% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$20.4M | +34.3% |
| Investing Cash Flow | -$801K | +66.8% |
| Financing Cash Flow | $35.9M | +626.6% |
| $115.3M |
| +5.7% |
| Stockholders' Equity | $22.4M | -19.2% |